Press release content from Business Wire. The AP news staff was not involved in its creation.
Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
March 4, 2021 GMT
Tenax Therapeutics, Inc. (Nasdaq: TENX),
a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced that management will present a company overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021.
The pre-recorded presentation will be available for viewing on-demand beginning March 9 at 7:00 A.M. (EST). This presentation will also be available on the Investors section of Tenax Therapeutics’ website at tenaxthera.com.